The proposed EGIR definition excluded subjects with diabetes because of difficulties in measuring insulin resistance in these individuals as beta-cell dysfunction, a key characteristic of T2DM, makes estimates of insulin sensitivity unreliable. The gene discussed is INS; the disease is type 2 diabetes mellitus.